UNSPSC 85512720: Supplement left common iliac artery with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left common iliac artery with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UD3JZ

UNSPSC 85512720 Supplement left common iliac artery with synthetic substitute, percutaneous approach is a Commodity code that shows little relevant recent activity in state and local procurement. The code nominally describes a specific surgical procedure — vascular system augmentation — yet the most recently posted state and local opportunities tagged to this code are unrelated to procedural interventions. Instead, the opportunities address occupational medical surveillance, independent medical evaluations for pension disability determinations, surgical benefit carve-out administration, pharmacy benefit management, temporary health professional staffing, and emergency medical services for youth in custody. None of these solicitations involve vascular grafting, arterial supplementation, or the procedural medical device procurement that the code's title implies. The mismatch suggests either a data-entry error in the source material or that state and local procurement offices have tagged administrative and workforce-management health services to a code designed for device or procedure-level medical taxonomy — a pattern that diminishes the code's utility for vendors pursuing actual device or procedural supply work.

The geographic and issuing-body spread across the unrelated opportunities spans California (City of Long Beach, County of Santa Clara), Arizona (City of Phoenix), Washington (Washington State Department of Transportation), Florida (Collier County), and Texas (Harris County), with a mix of county procurement offices, municipal governments, state departments, and health systems. Without a coherent block of opportunities aligned to vascular supplementation or related procedural supplies, business development efforts under this code should focus on clarifying the source-data issue with procurement offices or pursuing opportunities coded to device-supply or surgical-services categories that more directly reflect vascular intervention work.